Clinical Trials
792 trialsTumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis
Minia University
Predicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
TRAP
Royal Marsden NHS Foundation Trust
Radiosurgery Before Surgery for the Treatment of Brain Metastases
Emory University
CIREL
Cardiovascular and Interventional Radiological Society of Europe
CIEMAR
Cardiovascular and Interventional Radiological Society of Europe
OLIGO
Fundacao Champalimaud
TARSARC
Institut Bergonié
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
University of California, Irvine
VEXILLUM
Spanish Oncology Genito-Urinary Group
Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
PERMED01
Institut Paoli-Calmettes
CONGRATS
Institut Bergonié
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Institut Claudius Regaud
CREDO
Institut Claudius Regaud
Telerehabilitation in Oncology Patients
University of Malaga
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
AMMAM
Centre Hospitalier Universitaire de Nice
A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Dana-Farber Cancer Institute
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
HonorHealth Research Institute
Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer
Ruijin Hospital
ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors
M.D. Anderson Cancer Center
COLOCROSS
Centre Oscar Lambret
IPSY
Centre Oscar Lambret
REGO-SARC
Centre Oscar Lambret
Advance Care Planning in the Emergency Department
Brigham and Women's Hospital
ESOP
Assistance Publique - Hôpitaux de Paris
TRIPLET
Federation Francophone de Cancerologie Digestive
Fulvestrant With or Without Ganetespib in HR+ Breast Cancer
Dana-Farber Cancer Institute
Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer
Fred Hutchinson Cancer Center
Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
Ohio State University Comprehensive Cancer Center
Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
METIMMOX
University Hospital, Akershus
Clinical-pathological Characterization and Outcomes of Metastatic Urothelial Cancer in Latin America
Latin American Cooperative Oncology Group
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
EARDIS
Centre Hospitalier Universitaire de Nīmes
FEGALA
Centre Paul Strauss
GENDER-HCC-MET
Tongji University
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
University of California, San Diego
TEMPLE
Rigshospitalet, Denmark
A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
University Health Network, Toronto
Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
University of Pittsburgh
A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC
Massachusetts General Hospital
IMPACT
Indiana University
BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers
M.D. Anderson Cancer Center
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
Abramson Cancer Center at Penn Medicine
SHIVA
Institut Curie
DYSLIM
Assistance Publique - Hôpitaux de Paris
QUEPAL
Institut Curie
PERISAFE
Assistance Publique - Hôpitaux de Paris